Αρχική World News No Survival Advantage from Radical Hysterectomy in Patients with Cervical Cancer and...

No Survival Advantage from Radical Hysterectomy in Patients with Cervical Cancer and Intraoperative Detection of Positive Lymph Node Involvement

No significant difference was observed in the risk of recurrence, local recurrence, or death between patients with cervical cancer in whom radical uterine procedure (mostly radical hysterectomy) was completed or abandoned upon intraoperative detection of a positive pelvic lymph node (LN). These findings from a retrospective observational international ABRAX study were presented by Prof. David Cibula of the Gynaecologic Oncology Centre, Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic at the ESMO Virtual Congress 2020.

Prof. Cibula discussed the controversy regarding the management of patients with cervical cancer who are diagnosed with positive pelvic LNs intraoperatively. Current clinical practice is almost equally divided between two different types of managements. He noted that extensive surgical dissection in the pelvis followed by pelvic radiotherapy has been related with higher morbidity since both treatment modalities are associated with different types of adverse events.

Prof. Cibula and colleagues conducted the ABRAX study to evaluate whether the completion of radical hysterectomy improves the outcome in these patients.

The ABRAX multicentre, retrospective, cohort study data comprised 515 patients who were referred for primary surgery with a curative intent between 2005 and 2015 for stage IA-IIB tumours and were subsequently found to be LN positive during the surgery. LNs with metastasis ≥0.2 mm were considered positive (N1).

The patients were stratified according to the type of surgical management  into two subgroups: the COMPL group included 361 patients in whom uterine procedure was completed as planned (92.8% radical hysterectomy; 3.9% simple hysterectomy; 2.5% radical trachelectomy; 0.6% simple trachelectomy), and the ABAND group of 154 patients in whom uterine procedure was abandoned based on intraoperative detection of LN positivity. Traditional prognostic markers, such as tumour size, tumour type and disease stage were balanced between the two groups. By propensity score matching, none of the outcome endpoint was influenced by the type of the management after removal of other potentially relevant covariates. Additional treatment administered included adjuvant chemoradiation in 75%, combined radiotherapy in 13% and chemotherapy only in 17% of the COMPL group and primary chemoradiation in 93% and primary combined radiotherapy in 7% of patients in the ABAND group.

With median follow-up of 48.9 months, 381 (74%) patients in the overall population maintained disease free.

No significant difference was found between the two groupsregarding the risk of recurrence (hazard ratio [HR] 1.154; p = 0.446), local recurrence (HR 0.836; p = 0.557), or death (HR 1.064; p = 0.779).

Subgroup analyses did not identify a group of patients that showed a survival benefit from completing uterine surgery.

In the overall study cohort, increasing FIGO stage and tumour size ≥4 cm were identified as major prognostic factors that associated with the risk of recurrence and poorer survival.


Based on these results from the ABRAX study, the authors concluded that completion of radical hysterectomy in patients with intraoperative detection of positive LNs does not improve survival, irrespective of tumour size or tumour type.

Therefore, the investigators suggest that, if pelvic LN involvement is diagnosed at surgery, abandonment of planned uterine procedure should be considered and the patient should be referred to definitive chemoradiation.

Funding for this study was reported from the Charles University in Prague (UNCE 204065 and PROGRES Q28/LF1) and the Czech Research Council (No 16-31643A).


806O – Cibula D, Dostalek L, Hillemanns P, et al. Radical hysterectomy in cervical cancer patients with intraoperatively detected positive lymph node: ABRAX multicentric retrospective cohort study (ENGOT-Cx3/CEEGOG CX2). ESMO Virtual Congress 2020.



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Mothers Raise Girls Together After Discovering They Were Swapped At Birth

On New Years’ Even in 1998, two baby girls were born at a hospital in a Sicilian fishing port, Mazara del Vallo. The babies were...

Firefighters Band Together To Raise $30k For Breast Cancer Research & Care

Firefighters save lives as part of their job, but this group of firefighters are deemed heroes for more than just their firefighter duties. When they...

Foodie Friday: Butternut Squash Macaroni Casserole

As we move into fall, grocery stores and farmer’s markets are moving beautiful, health-filled butternut squash to their produce sections! When I saw this recipe...

Extra or Missing Chromosomes May Help Cancer Cells Survive Treatment

September 24, 2021, by NCI Staff Most healthy human cells have 23 pairs of chromosomes, 1 through 22, plus X and Y. Many cancer cells,...

A winding journey into the world of children’s and young people’s cancer research

“It seems strange trying to describe my career path, as the words imply that there was some sort of intention or plan as to...

Early Signs of Efficacy of New Targeted Agents and Immunotherapies Reported for Multiple Cancers at ESMO Congress 2021 [ESMO Congress 2021 Press Release]

LUGANO, Switzerland – Data from early clinical trials presented at the ESMO Congress 2021 suggest that new anticancer treatments are on the horizon, with...